129 studies found for:    glioblastoma | Open Studies | Exclude Unknown | Phase 2
Show Display Options
Rank Status Study
1 Recruiting Phase II Pazopanib Plus Topotecan for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Brain Neoplasms;   Central Nervous System Neoplasms
Interventions: Drug: Pazopanib;   Drug: Topotecan;   Behavioral: Symptom Questionnaire;   Behavioral: Phone Calls
2 Recruiting NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: Bevacizumab;   Device: NovoTTF-l00A;   Other: Quality of Life Assessment
3 Recruiting Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma
Interventions: Biological: bevacizumab;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Genetic: microarray analysis;   Genetic: DNA methylation analysis
4 Recruiting Phase 2 Study of Selinexor (KPT-330) in Patients With Recurrent Glioblastoma or Other Brain Cancers After Failure of Radiation and Temozolomide
Conditions: Glioblastoma;   Glioma
Intervention: Drug: Selinexor
5 Recruiting PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Conditions: Glioblastoma;   Cancer of Brain and Nervous System;   Glioblastoma Multiforme
Interventions: Drug: Temozolomide;   Procedure: Stereotactic Radiosurgery
6 Recruiting Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Conditions: Adult Brain Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: SL-701; Imiquimod Cream 5%; Leukine 150 micrograms;   Drug: Imiquimod Cream 5%;   Drug: Leukine 150 micrograms
7 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
8 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
9 Recruiting ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: ABT-414;   Drug: Lomustine;   Drug: Temozolomide
10 Recruiting Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
11 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia,;   Glioblastoma
Intervention: Drug: Romiplostim
12 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
13 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
14 Recruiting Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma
Conditions: Glioblastoma;   Astrocytoma
Intervention: Radiation: Rhenium Liposome Treatment
15 Recruiting Trial of Hypofractionated Radiation Therapy for Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Hypofractionated radiation therapy;   Radiation: Standard radiation therapy
16 Not yet recruiting Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma - Category
Interventions: Drug: Bevacizumab;   Procedure: Magnetic Resonance Spectroscopy (MRS);   Procedure: Border Zone Stereotactic Radiosurgery (BZ-SRS)
17 Recruiting Study of DC Vaccination Against Glioblastoma
Conditions: Glioma;   Glioblastoma Multiforme;   Neoplasms
Interventions: Procedure: Surgery;   Drug: Chemotherapy;   Radiation: Radiotherapy;   Biological: DC vaccination;   Drug: blank placebo
18 Recruiting INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
Condition: Glioblastoma Multiforme
Intervention: Radiation: Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy)
19 Not yet recruiting The Addition of Chloroquine to Chemoradiation for Glioblastoma,
Conditions: Glioblastoma;   Astrocytoma, Grade IV
Intervention: Drug: Chloroquine
20 Not yet recruiting MRSI Guided Dose Escalated Radiation in Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Intensity Modulated Radiation Therapy;   Drug: Temozolomide;   Device: Three Dimensional Volumetric MRS Imaging;   Behavioral: FACT-BR Questionnaire;   Radiation: Stereotactic Radiosurgery Boost;   Radiation: Simultaneous Integrated Boost;   Device: MRI

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years